Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Li Kei Ling, Executive. Insider active across 1 company, notably Dawnrays Pharmaceutical (Holdings) Ltd.. In total, 8 filings have been logged. History available since 30 March 2026. The latest transaction was filed on 25 June 2026 (Purchase). Regulator: HKEX. The full history is free.
84,000 shares@ €0.12140.0006% mcap29.2% of flowShareXHKGHKEX:DA20260331E00415
Ideal exit: 25 Dec 2026 (T+270)
8 of 8 declarations
About Li Kei Ling
Li Kei Ling is an executive at Dawnrays Pharmaceutical (Holdings) Ltd. She is involved in managing and strategizing for the company, which specializes in the pharmaceutical sector. Her role is essential for the development and innovation of the company.